Form 8-K Praxis Precision Medicin For: Jan 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Praxis Precision Medicines (PRAX) Teminates Open Market Sale Agreement
January 11, 2024 6:08 AM ESTAs previously disclosed, on December 7, 2023, Praxis Precision Medicines (NASDAQ: PRAX) entered into an Open Market Sale Agreement SM (the Sales Agreement) with Jefferies LLC (Jefferies), pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price... More



